|
| Michael R Jaff | From the Division of Pharmacoepidemiology and Pharmacoeconomics (J.J.J., Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Massachusetts General Hospital, Boston (M.R.J.) Baptist Cardiac and Vascular Institute, Florida International University School of Medicine, University Park (J.F.B.) Department of Vascular Therapy, Kaiser Foundation Hospital, St. Joseph Mercy Hospital, Mayo Clinic, Institute for Health Research, Kaiser Permanente Colorado, University of Colorado Denver (T.T.T.) Department of Cardiovascular Diseases of the Ochsner Clinical School of the University of Queensland, Ochsner Clinic Foundation, Duke Clinical Research Institute |
| Thomas G Brott | From the Division of Pharmacoepidemiology and Pharmacoeconomics (J.J.J., Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Massachusetts General Hospital, Boston (M.R.J.) Baptist Cardiac and Vascular Institute, Florida International University School of Medicine, University Park (J.F.B.) Department of Vascular Therapy, Kaiser Foundation Hospital, St. Joseph Mercy Hospital, Mayo Clinic, Institute for Health Research, Kaiser Permanente Colorado, University of Colorado Denver (T.T.T.) Department of Cardiovascular Diseases of the Ochsner Clinical School of the University of Queensland, Ochsner Clinic Foundation, Duke Clinical Research Institute |
| Thomas T Tsai | From the Division of Pharmacoepidemiology and Pharmacoeconomics (J.J.J., Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Massachusetts General Hospital, Boston (M.R.J.) Baptist Cardiac and Vascular Institute, Florida International University School of Medicine, University Park (J.F.B.) Department of Vascular Therapy, Kaiser Foundation Hospital, St. Joseph Mercy Hospital, Mayo Clinic, Institute for Health Research, Kaiser Permanente Colorado, University of Colorado Denver (T.T.T.) Department of Cardiovascular Diseases of the Ochsner Clinical School of the University of Queensland, Ochsner Clinic Foundation, Duke Clinical Research Institute |
| Christopher J White | From the Division of Pharmacoepidemiology and Pharmacoeconomics (J.J.J., Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Massachusetts General Hospital, Boston (M.R.J.) Baptist Cardiac and Vascular Institute, Florida International University School of Medicine, University Park (J.F.B.) Department of Vascular Therapy, Kaiser Foundation Hospital, St. Joseph Mercy Hospital, Mayo Clinic, Institute for Health Research, Kaiser Permanente Colorado, University of Colorado Denver (T.T.T.) Department of Cardiovascular Diseases of the Ochsner Clinical School of the University of Queensland, Ochsner Clinic Foundation, Duke Clinical Research Institute |
| Soko Setoguchi | From the Division of Pharmacoepidemiology and Pharmacoeconomics (J.J.J., Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Massachusetts General Hospital, Boston (M.R.J.) Baptist Cardiac and Vascular Institute, Florida International University School of Medicine, University Park (J.F.B.) Department of Vascular Therapy, Kaiser Foundation Hospital, St. Joseph Mercy Hospital, Mayo Clinic, Institute for Health Research, Kaiser Permanente Colorado, University of Colorado Denver (T.T.T.) Department of Cardiovascular Diseases of the Ochsner Clinical School of the University of Queensland, Ochsner Clinic Foundation, Duke Clinical Research Institute |